Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Catalyst Pharmaceuticals (CPRX) Gross Profit: 2010-2024

Historic Gross Profit for Catalyst Pharmaceuticals (CPRX) over the last 8 years, with Dec 2024 value amounting to $422.9 million.

  • Catalyst Pharmaceuticals' Gross Profit rose 14.92% to $125.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $495.4 million, marking a year-over-year increase of 24.63%. This contributed to the annual value of $422.9 million for FY2024, which is 22.14% up from last year.
  • According to the latest figures from FY2024, Catalyst Pharmaceuticals' Gross Profit is $422.9 million, which was up 22.14% from $346.2 million recorded in FY2023.
  • In the past 5 years, Catalyst Pharmaceuticals' Gross Profit registered a high of $422.9 million during FY2024, and its lowest value of $102.0 million during FY2020.
  • In the last 3 years, Catalyst Pharmaceuticals' Gross Profit had a median value of $346.2 million in 2023 and averaged $316.3 million.
  • Data for Catalyst Pharmaceuticals' Gross Profit shows a peak YoY soared of 92.56% (in 2023) over the last 5 years.
  • Catalyst Pharmaceuticals' Gross Profit (Yearly) stood at $102.0 million in 2020, then grew by 16.58% to $118.9 million in 2021, then skyrocketed by 51.17% to $179.8 million in 2022, then soared by 92.56% to $346.2 million in 2023, then rose by 22.14% to $422.9 million in 2024.